RSS feed

Publications by Jørn E. Thoen

12 publications found

Original articles

Kirkhus E, Bjørnerud A, Thoen J, Johnston V, Dale K, Smith HJ (2006)
Contrast-enhanced dynamic magnetic resonance imaging of finger joints in osteoarthritis and rheumatoid arthritis: an analysis based on pharmacokinetic modeling
Acta Radiol, 47 (8), 845-51
DOI 10.1080/02841850600838210, PubMed 17050366

Bohnhorst JØ, Bjørgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM (2002)
Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration
Clin Immunol, 103 (1), 79-88
DOI 10.1006/clim.2002.5199, PubMed 11987988

Bohnhorst JO, Thoen JE, Natvig JB, Thompson KM (2001)
Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjögren's syndrome
Scand J Immunol, 54 (4), 421-7
DOI 10.1046/j.1365-3083.2001.00989.x, PubMed 11555410

Bohnhorst JØ, Bjørgan MB, Thoen JE, Natvig JB, Thompson KM (2001)
Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome
J Immunol, 167 (7), 3610-8
DOI 10.4049/jimmunol.167.7.3610, PubMed 11564773

Omtvedt LA, Kolset SO, Thoen J, Førre Y, Gill MR (2001)
Serglycin expression in CD2+ and CD14+ cells from patients with various rheumatic diseases
Scand J Rheumatol, 30 (3), 164-6
DOI 10.1080/030097401300162941, PubMed 11469527

Fraser DA, Thoen J, Selvaag AM, Djøseland O, Førre O, Kjeldsen-Kragh J (2001)
A preliminary study of circadian serum cortisol concentrations in response to a 72-hour fast in rheumatoid arthritis patients not previously treated with corticosteroids
Clin Rheumatol, 20 (2), 85-7
DOI 10.1007/s100670170075, PubMed 11346236

Li S, Quayle AJ, Thoen JE, Førre OT (1996)
Superantigen-mediated proliferation and cytotoxicity of T cells isolated from the inflammatory tissues and peripheral blood of arthritis patients
Clin Immunol Immunopathol, 79 (3), 278-87
DOI 10.1006/clin.1996.0080, PubMed 8635287

Glennås A, Kvien TK, Melby K, Refvem OK, Andrup O, Karstensen B, Thoen JE (1995)
Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome
Br J Rheumatol, 34 (1), 45-50
DOI 10.1093/rheumatology/34.1.45, PubMed 7881838

Glennås A, Kvien TK, Melby K, Overbøo A, Andrup O, Karstensen B, Thoen JE (1994)
Reactive arthritis: a favorable 2 year course and outcome, independent of triggering agent and HLA-B27
J Rheumatol, 21 (12), 2274-80
PubMed 7699628

Kvien TK, Glennås A, Melby K, Granfors K, Andrup O, Karstensen B, Thoen JE (1994)
Reactive arthritis: incidence, triggering agents and clinical presentation
J Rheumatol, 21 (1), 115-22
PubMed 8151565

Hundal O, Kvien TK, Glennås A, Andrup O, Karstensen B, Thoen JE, Rugstad HE (1993)
Total and free plasma and total synovial fluid piroxicam concentrations: relationship to antiinflammatory effect in patients with reactive arthritis and other arthritides
Scand J Rheumatol, 22 (4), 183-7
DOI 10.3109/03009749309099268, PubMed 8356411

Theses

Thoen JE (1990)
Studies on T cell subpopulations and natural killer cellsin chronic inflammatory joint diseases
Institute of Immunology and Rheumatology, The National Hospital, Oslo, 1 b. (flere pag.)
BIBSYS 911292934, ISBN 82-90522-13-4